Diabetes Drugs Do Not Reduce Inflammation

This Harvard study shows evidence that although metformin (a commonly used diabetes medication) and insulin lower blood glucose, they do not reduce key inflammatory biomarkers. With these medications the blood sugar goes down, but the inflammation continues. These inflammatory biomarkers are associated with a host of chronic diseases: cardiovascular, cancer, autoimmune, etc. Moreover, "recent-onset type 2" diabetics were assessed. The damage starts before the diagnosis.